Article

Ambiguous Mammograms: An Emotional and Financial Burden

A study published in a supplement to the Journal of Women's Health looks to the widespread impact of newer screening technologies to improve outcomes.

breast cancer

One of every 7 women who undergo annual mammography screening for will be called back for follow-up tests.

These women can worry for days or weeks that the "suspicious" finding the radiologist has seen on their mammogram will be cancer. They might also incur direct and indirect medical costs.

A supplement to the September issue of the Journal of Women's Health highlights the burden, both financial and personal, of screening recall, and outlines some of the newer technologies for imaging the breast that could improve the accuracy of screening and make it more cost efficient.

breast cancer screening

"Our goal in is to find the most cancers at the lowest cost," Susan C. Harvey, MD, from Johns Hopkins Medical Institutions in Baltimore, told Medscape Medical News. "We want to up our value."

Link to report on Medscape: http://bit.ly/1mYRNe0

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
CK Wang, MD, COTA
Eric Lander, MD
Eric Lander, MD
David Awad, PharmD, BCOP
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo